Articles On Zoono Group (ASX:ZNO)

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Global share markets rally continue to rally in November despite ongoing economic and geopolitical pressures Avenira led the gainers in November after reporting a positive update on its proposed DSO Phosphate Project Gut health company Mic...

ASX health stocks have been out of favour this year with rotation away from growth to value sector Morgan’s Scott Power said a lot of biotechs aren’t able to convert their complex science into layman’s terms Hot money going to lithium and...

ASX 200 surges over 1.6% post-RBA meeting Small cap index finds 1% Hang Seng jumps 4% in HK, at last The local market had a bit of a moment when the Reserve Bank lifted the cash rate by another 0.25 basis points to 2.85%, the benchmark en...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX closes out the day lower by about 0.74% Online matchmakers Love Group goes on a bodice-busting 39% jag Woman tries to stop eviction with a swarm of bees. No, really…   Aussie markets are set to meander to a close around 0.74% down for...

We take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks from 2021 have gained since listing We also look at the best and worst performing ASX stocks over the past month   There were 191 ASX IPOs in...

Global biotech company Zoono (ZNO) develops a nasal spray to treat chronic rhinosinusitisIn partnership with the Faculty of Medical and Health Sciences at the University of Auckland, testing saw the eradication of bacteria found in patients...

Well… after a very pleasant weekend to ease us into the warmer months (except for our Victorian friends, who are dealing with several massive new swimming pools that nobody ordered. Poor buggers – we’d ask you all to dig deep, but it might...

US FDA approves the first clinical trial using naturally derived psychedelic drugs It could open possibilities for other clinical trials to follow suit Best and worst biotechs over the past month In a ground-breaking development, the US F...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

ASX Emerging Companies (XEC) index has closed 0.8% lower on Thursday Monday winners: Australian Vanadium Limited (ASX:AVL), Roots Sustainable Agricultural Technologies (ASX:ROO)  Monday losers: Hawsons Iron Ore (ASX:HIO), Icannex Healthcar...

Highlights The ASX Small Ordinaries index was trading flat by 12:30 PM AEDT, after plunging to a low of 3,315.7 in early trade. VRC, BKY and ZNO are three ASX penny stocks making big gains today. A conservative position sizing is reco...

Make it three on the trot for the ASX microcap Emerging Companies index, which rose by more than 1% for the third straight session on Friday. The gains follow a broader turnaround in global risk sentiment this week, following the initial sh...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

The ASX200 has vacillated all of Monday in a whiny, unattractive way for a major global index. Like a Kardashian (name one) unable to get out of bed, the heavyweight financial names and the major miners are just dragging everyone lower, dow...

It was a lacklustre session for local stocks in Tuesday trade, as the ASX 200 limped into the close with a fall of 0.77% while the microcap Emerging Companies index traded flat. In an environment of rising bond yields, the broader tone is s...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The Zoono Group Ltd (ASX: ZNO) share price took flight in trading today. This came after the company released its quarterly activities report. At the end of Thursday’s session, shares in the antimicrobial solutions company were 26.55% abo...

Local stocks posted a strong session on Thursday, as the ASX 200 climbed by around 1% while the microcap Emerging Markets index jumped again (+1.9%). Asian markets were buoyant more broadly, following a steady session on Wall Street overnig...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

Summary When a global crisis happens, investors often move towards safe haven assets such as gold, which acts as a catalyst for the business of gold miners. During a lockdown, owning high-quality blue-chip stocks is generally a good id...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The Zoono Group Ltd (ASX: ZNO) share price slipped into the red in today’s session. The dip arrives as Zoono announced its progress for the quarter. Let’s comb over the company’s results and highlights in finer detail. Quick refresher on...

The ASX tech sector succumbed to the latest selloff in tech equities globally. dragging the rest of the bourse down with it. The ASX 200 retreated 0.7% to close at 7,379 points while the ASX Emerging Companies Index lost 1.06%, closing at 2...

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

If you want to know which ASX stocks fund managers and famous investors are becoming and ceasing to be substantial shareholders of, we’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of the substantial holder...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

The ASX finished in positive territory, although short of an all-time high. The ASX 200 closed 0.15 per cent higher at 7,293 having traded as high as 7,316 in intraday trade. Meanwhile, the ASX Emerging Companies Index retreated 0.40 per ce...

Summary Australia is making progress towards economic recovery to get people back to work. Crowd Media Holdings marked the March quarter with the first SaaS licence signed for its AI platform. GPT Group highlighted that the economic r...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

In today’s Money Morning…known knowns: we have effective vaccines…known unknowns: virus variants will emerge…unknown unknowns: social factors of ‘new money’…and more… In today’s episode of The Money Morning Podcast I speak with Paul Hyslo...

Closing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday t...

ASX stocks have closed for the Easter weekend on a high today in a result driven be tech and resources. The ASX 200 finished at 6,829 points, which was 0.56 per cent higher than yesterday. Small caps did even better with the ASX Emerging Co...

Biotech Zoono (ASX:ZNO) has seen its share price surge by close to 50 per cent today, after announcing that its Microbe Shield has successfully tested in the US against Human Coronavirus 229E. The Microbe Shield is a surface sanitiser that...

The Zoono Group Ltd (ASX: ZNO) share price is flying higher today after the sanitiser producer released a company update. The announcement contained several positive pieces of information. At the time of writing, the Zoono share price has...

Source:ITTIGallery, Shutterstock Summary Red Sky Energy was up by a massive 125 per cent yesterday and today it is up by another 44.4 per cent. Zoono has announced a host of key updates regarding some recent developments of the busine...

It has been a volatile day, but in late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to start the month with a gain. At the time of writing, the benchmark index is up 0.2% to 6,805.4 points. Four ASX shares that are clim...